Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Roche Media News directly as they happen.
Follow now 279 followers
Last updated 2 days ago
2 days ago
Over 24 weeks, a once-weekly subcutaneous injection of CT-388 achieved a clinically...
3 days ago
More than half of all U.S. cervical cancer patients are underscreened1, which...
24 days ago
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in...
29 days ago
Approval based on Phase III ALINA study showing Alecensa reduced the risk...
about 1 month ago
Results from the Phase III study showed that subcutaneous (SC) injection was...
about 1 month ago
Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall...
about 1 month ago
The Elecsys® pTau217 plasma biomarker test is being developed as part of...
about 2 months ago
2 months ago
All proposals of the Board of Directors approvedSeverin Schwan re-elected as Chairman...
2 months ago
KARDIA-2 study met its primary endpoint, demonstrating clinically significant systolic blood pressure...
3 months ago
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with...
3 months ago
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study...